Genfit SA (NASDAQ:GNFT)
| 15.63 Delayed Data As of 4:00pm ET |  -1.22 / -7.24%Today’s Change | 13.21 Today|||52-Week Range 26.25 | -21.46% Year-to-Date |
Latest GNFT News | Press Releases
| Is Viking Therapeutics' Stock a Buy? Feb 18 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 16.85 |
| Today’s open | 16.35 |
| Day’s range | 15.33 - 16.64 |
| Volume | 119,071 |
| Average volume (3 months) | 56,923 |
| Market cap | $697.0M |
Data as of 4:00pm ET, 02/25/2020
Growth & Valuation
| Earnings growth (last year) | -41.89% |
| Earnings growth (this year) | -1.13% |
| Earnings growth (next 5 years) | -21.80% |
| Revenue growth (last year) | -38.84% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 23.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ASMBAssembly Biosciences... | -1.04 | -5.04% |
| GTHXG1 Therapeutics Inc | +0.25 | +1.46% |
| SVASinovac Biotech Ltd | 0.00 | 0.00% |
| ARDXArdelyx Inc | -0.63 | -8.27% |
Data as of 4:00pm ET, 02/25/2020
Financials
| Last reporting date | October 1, 2019 |
| EPS forecast (this quarter) | -$0.77 |
| Annual revenue (last year) | $81.4K |
| Annual profit (last year) | -$93.8M |
| Net profit margin | -115,247.83% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Loos, Nord-pas-de-calais |
Forecasts
